165 related articles for article (PubMed ID: 2888898)
1. Antipsychotic activity of substituted gamma-carbolines.
Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
J Med Chem; 1987 Oct; 30(10):1818-23. PubMed ID: 2888898
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic agents: synthesis and antipsychotic activity of substituted beta-carbolines.
Abou-Gharbia M; Patel UR; Moyer JA; Muth EA
J Med Chem; 1987 Jun; 30(6):1100-5. PubMed ID: 2884314
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents.
Abou-Gharbia M; Moyer JA; Patel U; Webb M; Schiehser G; Andree T; Haskins JT
J Med Chem; 1989 May; 32(5):1024-33. PubMed ID: 2565399
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic activity in 5-aryltetrahydro-gamma-carbolines.
Harbert CA; Plattner JJ; Welch WM; Weissman A; Koe BK
J Med Chem; 1980 Jun; 23(6):635-43. PubMed ID: 6104732
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic activity of the 5-aryltetrahydro-gamma-carboline series. Conformational requirements for interaction with central dopamine receptors.
Harbert CA; Plattner JJ; Welch WM; Weissman A; Koe BK
Mol Pharmacol; 1980 Jan; 17(1):38-42. PubMed ID: 6104285
[No Abstract] [Full Text] [Related]
7. Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies.
Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
J Med Chem; 1988 Jul; 31(7):1382-92. PubMed ID: 2898533
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
Hrib NJ; Jurcak JG; Huger FP; Errico CL; Dunn RW
J Med Chem; 1991 Mar; 34(3):1068-72. PubMed ID: 1672156
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.
Hrib NJ; Jurcak JG; Bregna DE; Burgher KL; Hartman HB; Kafka S; Kerman LL; Kongsamut S; Roehr JE; Szewczak MR; Woods-Kettelberger AT; Corbett R
J Med Chem; 1996 Sep; 39(20):4044-57. PubMed ID: 8831770
[TBL] [Abstract][Full Text] [Related]
10. Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
Agai-Csongor E; Nógrádi K; Galambos J; Vágó I; Bielik A; Magdó I; Ignácz-Szendrei G; Keseru GM; Greiner I; Laszlovszky I; Schmidt E; Kiss B; Sághy K; Laszy J; Gyertyán I; Zájer-Balázs M; Gémesi L; Domány G
Bioorg Med Chem Lett; 2007 Oct; 17(19):5340-4. PubMed ID: 17720494
[TBL] [Abstract][Full Text] [Related]
11. DuP 734 [1-(cyclopropylmethyl)-4-(2'(4''-fluorophenyl)-2'- oxoethyl)piperidine HBr], a potential antipsychotic agent: preclinical behavioral effects.
Cook L; Tam SW; Rohrbach KW
J Pharmacol Exp Ther; 1992 Dec; 263(3):1159-66. PubMed ID: 1361571
[TBL] [Abstract][Full Text] [Related]
12. 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 2.
van Wijngaarden I; Kruse CG; van der Heyden JA; Tulp MT
J Med Chem; 1988 Oct; 31(10):1934-40. PubMed ID: 2902226
[TBL] [Abstract][Full Text] [Related]
13. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
14. Blockade of hippocampal dopamine (DA) receptors: a tool for antipsychotics with low extrapyramidal side effects.
Bischoff S; Christen P; Vassout A
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):455-67. PubMed ID: 2900538
[TBL] [Abstract][Full Text] [Related]
15. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
[TBL] [Abstract][Full Text] [Related]
16. 6-(alkylamino)-9-alkylpurines. A new class of potential antipsychotic agents.
Kelley JL; Bullock RM; Krochmal MP; McLean EW; Linn JA; Durcan MJ; Cooper BR
J Med Chem; 1997 Sep; 40(20):3207-16. PubMed ID: 9379440
[TBL] [Abstract][Full Text] [Related]
17. Effects of typical and atypical antipsychotic drugs on two-way active avoidance. Relationship to DA receptor blocking profile.
Ogren SO; Archer T
Psychopharmacology (Berl); 1994 Apr; 114(3):383-91. PubMed ID: 7855196
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological characterization of alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents.
Yevich JP; New JS; Lobeck WG; Dextraze P; Bernstein E; Taylor DP; Yocca FD; Eison MS; Temple DL
J Med Chem; 1992 Nov; 35(24):4516-25. PubMed ID: 1361578
[TBL] [Abstract][Full Text] [Related]
19. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Norman MH; Rigdon GC; Navas F; Cooper BR
J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
[TBL] [Abstract][Full Text] [Related]
20. 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.
Howard HR; Lowe JA; Seeger TF; Seymour PA; Zorn SH; Maloney PR; Ewing FE; Newman ME; Schmidt AW; Furman JS; Robinson GL; Jackson E; Johnson C; Morrone J
J Med Chem; 1996 Jan; 39(1):143-8. PubMed ID: 8568801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
